Effects of serum containing chinese medicine sanpi pingwei formula on proliferation and apoptosis of human SGC-7901 cells

Chinese Journal of Integrative Medicine

Volumn 19, Issue 2, 2013, Pages 119-126

  Dang, Xiao Yan ^a   Dong, Lei ^a   Shi, Hai Tao ^a   Zou, Bai Cang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Chinese medicine; Stomach neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PROTEIN; FLUOROURACIL; HERBACEOUS AGENT; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SANPI PINGWEI; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL LEVEL; CELL LINE; CELL PROLIFERATION; CHINESE HERB; CHINESE MEDICINE; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; DRUG SYNTHESIS; FISSISTIGMA GLAUCESCENS; FLOW CYTOMETRY; FRUCTUS AURANTII IMMATURUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LOW DRUG DOSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RADIX ASTRAGALI; RADIX GLYCYRRHIZAE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RHIZOMA PINELLIAE; SCYTEKARUABARBVATA; SERUM GROUP; UPREGULATION; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SERUM; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SERUM; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884379429     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1208-6     Document Type: Article

References (31)

1. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Iacobuzio-Donahue CA, et al. Claudin-4, mitogenactivated protein kinase kinase 4, and stratifin aremarkers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev 2006;15:281-287.
2. Meireles SI, Cristo EB, Carvalho AF, Hirata R Jr, Pelosof A, Gomes LI, et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res 2004;64:1255-1265.
3. Valentini V, Cellini F, Minsky BD, Mattiucci GC, Balducci M, D'Agostino G, et al. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol 2009;92:176-183.
4. Varadhachary G, Ajani JA. Gastric cancer. Clin Adv Hematol Oncol 2005;3:118-124.
5. Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, et al. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected highrisk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. Ann Oncol 2005;16:1326-1333.
6. Lin WL, Li DG, Chen Q, Lu HM. Clinical and experimental study of oxaliplatin in treating human gastric carcinoma. World J Gastroenterol 2004;10:2911-2915.
7. Abe M, Nishimura Y, Shibamoto Y. Intraoperative radiation therapy for gastric cancer. World J Surg 1995;19:544-547.
8. Klautke G, Foitzik T, Ludwig K, Ketterer P, Klar E, Fietkau R. Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma. Strahlenther Onkol 2004;180:695-700.
9. Zuo Y, Xu M, Shen D, Lu WD, Lu JF. Postoperative intraperitioneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patients. Chin J Oncol (Chin) 2004;26:247-249.
10. Bozzetti F, Vaglini M, Deraco M. Intraperitoneal hyperthermic chemotherapy in gastric cancer: rationale for a new approach. Tumor 1998;84:483-488.
11. Yamauchi K, Yang M, Hayashi K, Jiang P, Yamamoto N, Tsuchiya H. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res 2008;68:516-520.
12. Orr FW, Adamson IY, Young L. Promotion of pulmonary metastasis in mice by bleomycin-induced endothelial injury. Cancer Res 1986;46:891-897.
13. Chau GY, Lui WY, Tsay SH, Chao Y, King KL, Wu CW. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study. Ann Surg Oncol 2006;13:1329-1337.
14. Ono T, Yamanoi A, Nazmy El, Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: meta analysis of three randomized controlled trials. Cancer 2001;91:2378-2385.
15. Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drugresistant cancer. Cancer Res 2000;60:1878-1886.
16. Yu J, Liu H, Lei J, Tan W, Hu X, Zou G. Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytoher Res 2007;21:817-822.
17. Yin X, Zhou J, Jie C, Xing D, Zhang Y. Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 2004;75:2233-2244.
18. Wang WJ, Li DJ, Li J, Zhou WJ. An in vitro study on neuroprotective effects of serum containing Gengnianchun decoction and its main monomers against amyloid beta protein-induced cellular toxicity. J Chin Integr Med (Chin) 2010;8:67-73.
19. Korbakis D, Scorilas A. Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12. Tumor Biol 2009;30:100-107.
20. Sundblad AS, Tamayo R. Expression of MIB-1/KI-67and bcl-2 in gastric carcinoma. Relationship with clinico-pathological factors. Acta Gastroenterol Latinoam 1995;25:67-72.
21. Xu AG, Li SG, Liu JH. Significance of apoptosis and expression of bcl-2 in gastric precarcinoma and cancer. Guangdong Med J (Chin) 1998;19:489-490.
22. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppression tumorigenesis and stimulates apoptosis in vivo. Nature 1997;385:637-640.
23. Qiu Z, Zhu J, Harms JS, Friedrichsen J, Splitter GA. Bovine herpesvirus VP22 induces apoptosis in neuroblastoma cells by upregulating the expression ratio of Bax to Bcl-2. Hum Gene Ther 2005;16:101-108.
24. Zheng XL, Sun HX, Liu XL, Chen YX, Qian BC. Astilbic acid induced COLO 205 cell apoptosis by regulating Bcl-2 and Bax expression and activating caspase-3. Acta Pharmacol Sin 2004;25:1090-1095.
25. Bowen JM, Gibson RJ, Keefe DM, Cummins AG. Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology 2005;37:56-62.
26. Kok SH, Cheng SJ, Hong CY, Lee JJ, Lin SK, Kuo YS, et al. Norcantharidin induced apoptosis in oral cancer cells isassociated with an increase of proapoptotic to antiapoptotic. Cancer Lett 2005;217:43-52.
27. Piette J, Neel H, Maréchal V. Mdm2: keeping p53 under control. Oncogene 1997;15:1001-1010.
28. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604.
29. Lowe SW, Ruley HE, Jacks T, Housman DE. P53 dependent apoptosis modulates the cytoxicity of anticancer agents. Cell 1993;74:957-967.
30. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, et al. Immediate early up-regulation of bax expression by p53 but not TGFb1: a paradigm for distinct apoptotic pathways. Oncogene 1994;9:1791-1798.
31. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor P53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.